199 related articles for article (PubMed ID: 34820594)
1. Novel Circulating Hypermethylated RASSF1A ddPCR for Liquid Biopsies in Patients With Pediatric Solid Tumors.
van Zogchel LMJ; Lak NSM; Verhagen OJHM; Tissoudali A; Gussmalla Nuru M; Gelineau NU; Zappeij-Kannengieter L; Javadi A; Zijtregtop EAM; Merks JHM; van den Heuvel-Eibrink M; Schouten-van Meeteren AYN; Stutterheim J; van der Schoot CE; Tytgat GAM
JCO Precis Oncol; 2021; 5():. PubMed ID: 34820594
[TBL] [Abstract][Full Text] [Related]
2. Detection and monitoring of hypermethylated RASSF1A in serum from patients with metastatic breast cancer.
Kristiansen S; Nielsen D; Sölétormos G
Clin Epigenetics; 2016; 8():35. PubMed ID: 27042241
[TBL] [Abstract][Full Text] [Related]
3. Aberrant Promoter Hypermethylation of RASSF1a and BRCA1 in Circulating Cell-Free Tumor DNA Serves as a Biomarker of Ovarian Carcinoma.
S SK; Swamy SN; Premalatha CS; Pallavi VR; Gawari R
Asian Pac J Cancer Prev; 2019 Oct; 20(10):3001-3005. PubMed ID: 31653147
[TBL] [Abstract][Full Text] [Related]
4. [Detection of circulating hypermethylated tumor-specific RASSF1A DNA in ovarian cancer patients].
Ma L; Liu FR; Zhang SL
Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):785-7. PubMed ID: 16545186
[TBL] [Abstract][Full Text] [Related]
5. Methylated RASSF1a is the first specific DNA marker for minimal residual disease testing in neuroblastoma.
Stutterheim J; Ichou FA; den Ouden E; Versteeg R; Caron HN; Tytgat GA; van der Schoot CE
Clin Cancer Res; 2012 Feb; 18(3):808-14. PubMed ID: 22142825
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis.
Chan KC; Ding C; Gerovassili A; Yeung SW; Chiu RW; Leung TN; Lau TK; Chim SS; Chung GT; Nicolaides KH; Lo YM
Clin Chem; 2006 Dec; 52(12):2211-8. PubMed ID: 17068167
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma.
Chan KC; Lai PB; Mok TS; Chan HL; Ding C; Yeung SW; Lo YM
Clin Chem; 2008 Sep; 54(9):1528-36. PubMed ID: 18653827
[TBL] [Abstract][Full Text] [Related]
8. Highly Specific Droplet-Digital PCR Detection of Universally Methylated Circulating Tumor DNA in Endometrial Carcinoma.
Beinse G; Borghese B; Métairie M; Just PA; Poulet G; Garinet S; Parfait B; Didelot A; Bourreau C; Agueeff N; Lavollé A; Terris B; Chapron C; Goldwasser F; Leroy K; Blons H; Laurent-Puig P; Taly V; Alexandre J
Clin Chem; 2022 Jun; 68(6):782-793. PubMed ID: 35323926
[TBL] [Abstract][Full Text] [Related]
9. Association of fetal-derived hypermethylated RASSF1A concentration in placenta-mediated pregnancy complications.
Kim MJ; Kim SY; Park SY; Ahn HK; Chung JH; Ryu HM
Placenta; 2013 Jan; 34(1):57-61. PubMed ID: 23187089
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of fetal-derived hypermethylated RASSF1A sequence quantification in maternal plasma--next step toward reliable non-invasive prenatal diagnostics.
Zejskova L; Jancuskova T; Kotlabova K; Doucha J; Hromadnikova I
Exp Mol Pathol; 2010 Dec; 89(3):241-7. PubMed ID: 20868679
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylated
van Zogchel LMJ; van Wezel EM; van Wijk J; Stutterheim J; Bruins WSC; Zappeij-Kannegieter L; Slager TJE; Schumacher-Kuckelkorn R; Verly IRN; van der Schoot CE; Tytgat GAM
JCO Precis Oncol; 2020; 4():. PubMed ID: 32923888
[TBL] [Abstract][Full Text] [Related]
12. Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma.
Lak NSM; van Zogchel LMJ; Zappeij-Kannegieter L; Javadi A; van Paemel R; Vandeputte C; De Preter K; De Wilde B; Chicard M; Iddir Y; Schleiermacher G; Ruhen O; Shipley J; Fiocco M; Merks JHM; van Noesel MM; van der Schoot CE; Tytgat GAM; Stutterheim J
JCO Precis Oncol; 2023 Jan; 7():e2200113. PubMed ID: 36652664
[TBL] [Abstract][Full Text] [Related]
13. Elevated plasma levels of hypermethylated RASSF1A gene sequences in pregnant women with intrahepatic cholestasis.
Yi P; Yin N; Zheng Y; Jiang H; Yu X; Yan Y; Liu Q; Xiao F; Li L
Cell Biochem Biophys; 2013; 67(3):977-81. PubMed ID: 23579583
[TBL] [Abstract][Full Text] [Related]
14. Combining Hypermethylated
Lobo J; van Zogchel LMJ; Nuru MG; Gillis AJM; van der Schoot CE; Tytgat GAM; Looijenga LHJ
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680375
[TBL] [Abstract][Full Text] [Related]
15. Digital PCR-Based Detection of EGFR Mutations in Paired Plasma and CSF Samples of Lung Adenocarcinoma Patients with Central Nervous System Metastases.
Huang R; Xu X; Li D; Chen K; Zhan Q; Ge M; Zhou X; Liang X; Guan M
Target Oncol; 2019 Jun; 14(3):343-350. PubMed ID: 31161597
[TBL] [Abstract][Full Text] [Related]
16. RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker.
Misawa A; Tanaka S; Yagyu S; Tsuchiya K; Iehara T; Sugimoto T; Hosoi H
Br J Cancer; 2009 Jan; 100(2):399-404. PubMed ID: 19165202
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening.
Kloten V; Becker B; Winner K; Schrauder MG; Fasching PA; Anzeneder T; Veeck J; Hartmann A; Knüchel R; Dahl E
Breast Cancer Res; 2013 Jan; 15(1):R4. PubMed ID: 23320751
[TBL] [Abstract][Full Text] [Related]
18. Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma.
Lodrini M; Graef J; Thole-Kliesch TM; Astrahantseff K; Sprüssel A; Grimaldi M; Peitz C; Linke RB; Hollander JF; Lankes E; Künkele A; Oevermann L; Schwabe G; Fuchs J; Szymansky A; Schulte JH; Hundsdörfer P; Eckert C; Amthauer H; Eggert A; Deubzer HE
Clin Cancer Res; 2022 May; 28(9):1809-1820. PubMed ID: 35247920
[TBL] [Abstract][Full Text] [Related]
19. Targeted locus amplification to develop robust patient-specific assays for liquid biopsies in pediatric solid tumors.
van Zogchel LMJ; Lak NSM; Gelineau NU; Sergeeva I; Stelloo E; Swennenhuis J; Feitsma H; van Min M; Splinter E; Bleijs M; Groot Koerkamp M; Breunis W; Meister MT; Kholossy WH; Holstege FCP; Molenaar JJ; de Leng WWJ; Stutterheim J; van der Schoot CE; Tytgat GAM
Front Oncol; 2023; 13():1124737. PubMed ID: 37152023
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of RASSF1A promoter hypermethylation in serum DNA of non-small cell lung cancer].
Yu ZH; Wang YC; Chen LB; Song Y; Liu C; Xia XY; Lin Q; Ma CY
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):284-7. PubMed ID: 18788633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
